Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 18, 2026Journal of Drug Delivery and TherapeuticsOpen Access

Nanocarriers for Brain Targeting: Overcoming the Blood-Brain Barrier in Neuropharmacology

View Full Paper
Ask AI
Bookmark
Share

Authors

HNH V NishanthSTS TejaswiniSDSharuq Devoor

Discussion

Loading...

Member takes

Overview

Review discusses how nanocarriers enhance drug delivery to the brain, addressing neurological disorders.

Key Points

  • This review aims to explore nanocarrier-based drug delivery systems for overcoming barriers in brain targeting.
  • Discussed different classes of nanocarriers including liposomes and polymeric nanoparticles.
  • Outlined mechanisms by which nanocarriers cross the blood-brain barrier.
  • Highlighted therapeutic applications in conditions like Alzheimer's and Parkinson's diseases.
  • Nanocarriers enhance drug stability, improve bioavailability, and prolong circulation time.
  • Showed promising applications in treating neurological disorders despite challenges in toxicity and regulatory approval.
  • Identified various mechanisms of nanocarrier transport across the blood-brain barrier.

Cite This Study

Nishanth et al. (2026) studied this question.

synapsesocial.com/papers/6a338a4e630953a74978c6bfhttps://doi.org/10.22270/jddt.v16i6.7777
View Full Paper
Ask AI
Bookmark
Share